Insilico Medicine Revenue

Biotechnology Research • Boston, Massachusetts, United States • 201-500 Employees

Insilico Medicine revenue & valuation

Annual revenue	$75,000,000
Revenue per employee	$266,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$240,000,000
Total funding	No funding

Key Contacts at Insilico Medicine

Collin Bantle

Director, Nonclinical Development And Safety

Michael Benzinou

Senior Director Of Bd&L & Strategic Partnerships, Ai Platforms At Insilico Medicine

Shan Chen

Director Of Bioinformatics

Xing Liang

Director, Head Of Cmc

Yichen Liu

Director Clinical Operations

Lijun Zhang

Director

Chen Wang

Associate Director Of Data Management

Ahmed Al Suwaidi

Associate Director - Business Developement & Strategic Partnerships Middle East

金鑫刘

Associate Director Of Computational Chemistry

剑飞万

Associate Director Of Medchem

Company overview

Headquarters	1000 Massachusetts Ave, Boston, Massachusetts 02138, US
Website	insilico.com
NAICS	541714
SIC	737
Keywords	Drug Discovery, Artificial Intelligence, Deep Learning, Longevity, Aging Research, Biomarker Development, Reinforcement Learning, Gans, Generative Adversarial Networks, Gans-Rl
Founded	2014
Employees	201-500
Socials

Insilico Medicine Email Formats

Insilico Medicine uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@insilico.ai), used 32.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@insilico.ai	32.1%
{first name}	john@insilicomedicine.com	29.6%
{first initial}.{last name}	j.doe@insilico.com	22.2%

About Insilico Medicine

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Insilico Medicine has 123 employees across 16 departments.

Departments

Number of employees

Funding Data

Insilico Medicine has never raised funding before.

Insilico Medicine Tech Stack

Discover the technologies and tools that power Insilico Medicine's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Amazon Web Services

PaaS

DDoS-Guard

Security

reCAPTCHA

Security

Amazon SES

Google Tag Manager

Tag managers

jQuery

JavaScript libraries

Hammer.js

JavaScript libraries

Open Graph

Miscellaneous

Tilda

CMS

Google Analytics

Analytics

Google Font API

Font scripts

Frequently asked questions

Insilico Medicine is located in Boston, Massachusetts, US.

Insilico Medicine generates an estimated annual revenue of $75,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Insilico Medicine has an estimated valuation of $240,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Insilico Medicine was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Insilico Medicine has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.